NeurologyLive® Friday 5 — July 10, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Rethinking Clinical Trial Design and the Immune System in Multiple Sclerosis: Ahmed Obeidat, MD, PhD

In a recent interview at the 2026 CMSC Annual Meeting, Ahmed Obeidat, MD, PhD, associate professor of neurology at the Medical College of Wisconsin, discussed the need to reconsider clinical trial paradigms by recognizing the role of immune cells in MS. [WATCH TIME: 6 minutes]

2: Integrating Clinical Research Insights Into Multiple Sclerosis Practice: Mark Freedman, MD, MSc

In a recent interview at the 2026 CMSC Annual Meeting, Mark Freedman, MD, MSc, director of the multiple sclerosis research unit at Ottawa Hospital, discussed how integrating clinical research into MS practice enhances clinician expertise. [WATCH TIME: 5 minutes]

3: Assessing Symptom Severity and Quality of Life in Narcolepsy and Idiopathic Hypersomnia

In a recent Q&A, Kiran Maski, MD, MPH, a sleep medicine specialist at Boston Children's Hospital, and Julie Flygare, JD, the president and CEO at Project Sleep, discussed diagnostic and patient-reported outcome measures that aim to better capture the burden of central disorders of hypersomnolence.

4: NeuroVoices: Ahmet Hoke, MD, PhD, on Why Animal Models Still Have a Role in Neuropathy Research

In our latest NeuroVoices Q&A, Ahmet Hoke, MD, PhD, professor of neurology and neuroscience at Johns Hopkins University School of Medicine, discussed the ongoing debate around animal models in neuropathy research, the rise of iPSC-derived systems, and why he believes both approaches are needed going forward.

5: Diagnosing Immune-Mediated Small Fiber Neuropathy in Clinical Practice: Matthew Evans, BM, BCh, DPhil

In a recent interview at the 2026 PNS Annual Meeting, Matthew Evans, BM, BCh, DPhil, a consultant neurologist at the University of Oxford, discusses the diagnostic approach to small fiber neuropathy and the challenges of confirming immune-mediated disease. [WATCH TIME: 3 minutes]

Don’t have time to read or watch a full video interview? Click here to check out our shorts!